Clinical Trial Update: Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetic trial compares mometasone furoate alone versus in combination with indacaterol in pediatric asthma patients aged 6 to under 12, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Indacaterol (indacaterol)
• Mometasone furoate (Mometasone furoate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2023-07-27